Cited 0 times in Scipus Cited Count

Clinical pathway for enhanced recovery after surgery for gastric cancer: A prospective single-center phase II clinical trial for safety and efficacy

DC Field Value Language
dc.contributor.authorRoh, CK-
dc.contributor.authorSon, SY-
dc.contributor.authorLee, SY-
dc.contributor.authorHur, H-
dc.contributor.authorHan, SU-
dc.date.accessioned2022-10-24T05:53:38Z-
dc.date.available2022-10-24T05:53:38Z-
dc.date.issued2020-
dc.identifier.issn0022-4790-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/22350-
dc.description.abstractBACKGROUND: We aimed to evaluate the safety and efficacy of a clinical pathway (CP) for enhanced recovery after surgery (ERAS) in gastric cancer patients, including early oral feeding and discharge on postoperative day 4.

METHODS: We performed a prospective, single-center, phase II clinical trial. Based on proposed indications for an ERAS CP in our retrospective study, we enrolled 133 patients younger than 65 years who were undergoing minimally invasive subtotal gastrectomy. The primary endpoint was the ERAS CP completion rate. Secondary endpoints included complication, mortality, hospital stay, and readmission.

RESULTS: Among 133 patients, six patients were dropped out from this study. The ERAS CP completion rate (77.2%, 98 of 127) was comparable to the historical control group that completed a conventional CP (85.4%, P = .085). The postoperative complication incidence (13.4%, 15 of 127) was also similar to that of the conventional CP group (9.5%, P = .174). We identified reduced hospital stays (4.7 ± 1.3 vs 7.2±2.3 days; P < .001) and lower hospital costs ($7771 vs 8539; P < .001) in the ERAS CP group compared with the conventional CP group.

CONCLUSIONS: An ERAS CP can be safely and effectively adopted for patients with gastric cancer without increasing the complication rate and could shorten hospital stays.

TRIAL REGISTRATION: ClinicalTrials.gov (NCT01642953).
-
dc.language.isoen-
dc.subject.MESHCritical Pathways-
dc.subject.MESHEnhanced Recovery After Surgery-
dc.subject.MESHFemale-
dc.subject.MESHGastrectomy-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHMinimally Invasive Surgical Procedures-
dc.subject.MESHProspective Studies-
dc.subject.MESHStomach Neoplasms-
dc.titleClinical pathway for enhanced recovery after surgery for gastric cancer: A prospective single-center phase II clinical trial for safety and efficacy-
dc.typeArticle-
dc.identifier.pmid31930513-
dc.subject.keywordclinical pathway-
dc.subject.keywordclinical trial-
dc.subject.keywordenhanced recovery after surgery-
dc.subject.keywordgastrectomy-
dc.subject.keywordgastric cancer-
dc.contributor.affiliatedAuthorRoh, CK-
dc.contributor.affiliatedAuthorSon, SY-
dc.contributor.affiliatedAuthorLee, SY-
dc.contributor.affiliatedAuthorHur, H-
dc.contributor.affiliatedAuthorHan, SU-
dc.type.localJournal Papers-
dc.identifier.doi10.1002/jso.25837-
dc.citation.titleJournal of surgical oncology-
dc.citation.volume121-
dc.citation.number4-
dc.citation.date2020-
dc.citation.startPage662-
dc.citation.endPage669-
dc.identifier.bibliographicCitationJournal of surgical oncology, 121(4). : 662-669, 2020-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn1096-9098-
dc.relation.journalidJ000224790-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
Journal Papers > School of Medicine / Graduate School of Medicine > Anesthesiology & Pain Medicine
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse